THE US Food and Drug Administration has granted Priority Review Designation for a new drug to help prevent malaria.
Tafenoquine from 60 Degrees Pharmaceuticals was developed under a cooperative agreement with the US Army, and offers a weekly dosing regimen for malaria prophylaxis.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Feb 18